Literature DB >> 23012327

Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.

Joanne E Croudace1, Charlotte F Inman, Ben E Abbotts, Sandeep Nagra, Jane Nunnick, Prem Mahendra, Charles Craddock, Ram Malladi, Paul A H Moss.   

Abstract

Chemokines regulate the migration of hemopoietic cells and play an important role in the pathogenesis of many immune-mediated diseases. Intradermal recruitment of CD8(+) T cells by CXCL10 is a central feature of the pathogenesis of cutaneous acute GVHD (aGVHD), but very little is known about the pathogenesis of chronic GVHD (cGVHD). Serum concentrations of the 3 CXCR3-binding chemokines, CXCL9, CXCL10, and CXCL11, were found to be markedly increased in patients with active cGVHD of the skin (n = 8). An 80% decrease in CD4(+) cells expressing CXCR3 was seen in the blood of these patients (n = 5), whereas CD4(+) cells were increased in tissue biopsies and were clustered around the central arterioles of the dermis. The well-documented increase in expression of CXCL10 in aGVHD therefore diversifies in cGVHD to include additional members of the CXCR3-binding family and leads to preferential recruitment of CD4(+) T cells. These observations reveal a central role for chemokine-mediated recruitment of CXCR3(+) T cells in cGVHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012327     DOI: 10.1182/blood-2012-02-413260

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.

Authors:  Hong-Gang Ren; Djamilatou Adom; Sophie Paczesny
Journal:  Expert Rev Clin Immunol       Date:  2018-04-19       Impact factor: 4.473

2.  Transplant biomarkers ready for the clinic?

Authors:  Austin John Barrett
Journal:  Blood       Date:  2017-01-12       Impact factor: 22.113

3.  CXCL10: most consistent cGVHD biomarker?

Authors:  Sophie Paczesny; Mohammad Abu Zaid
Journal:  Blood       Date:  2016-06-16       Impact factor: 22.113

4.  Increased Th17/Treg ratio in chronic liver GVHD.

Authors:  F Malard; C Bossard; E Brissot; P Chevallier; T Guillaume; J Delaunay; J-F Mosnier; P Moreau; M Grégoire; B Gaugler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

5.  Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.

Authors:  Eli Maymon; Roberto Romero; Gaurav Bhatti; Piya Chaemsaithong; Nardhy Gomez-Lopez; Bogdan Panaitescu; Noppadol Chaiyasit; Percy Pacora; Zhong Dong; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2018-02-23       Impact factor: 1.901

6.  Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Authors:  Frances T Hakim; Sarfraz Memon; Ping Jin; Matin M Imanguli; Huan Wang; Najibah Rehman; Xiao-Yi Yan; Jeremy Rose; Jacqueline W Mays; Susan Dhamala; Veena Kapoor; William Telford; John Dickinson; Sean Davis; David Halverson; Haley B Naik; Kristin Baird; Daniel Fowler; David Stroncek; Edward W Cowen; Steven Z Pavletic; Ronald E Gress
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

7.  Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.

Authors:  M M Imanguli; E W Cowen; J Rose; S Dhamala; W Swaim; S Lafond; B Yagi; R E Gress; S Z Pavletic; F T Hakim
Journal:  Leukemia       Date:  2014-02-28       Impact factor: 11.528

Review 8.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

9.  Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

Authors:  Carrie L Kitko; John E Levine; Barry E Storer; Xiaoyu Chai; David A Fox; Thomas M Braun; Daniel R Couriel; Paul J Martin; Mary E Flowers; John A Hansen; Lawrence Chang; Megan Conlon; Bryan J Fiema; Rachel Morgan; Prae Pongtornpipat; Kelly Lamiman; James L M Ferrara; Stephanie J Lee; Sophie Paczesny
Journal:  Blood       Date:  2013-12-20       Impact factor: 22.113

10.  Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

Authors:  Mohammad Abu Zaid; Juan Wu; Cindy Wu; Brent R Logan; Jeffrey Yu; Corey Cutler; Joseph H Antin; Sophie Paczesny; Sung Won Choi
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.